Field guide / Story / Receipts pack TRUE, BUT Self-Marked
Every author works for Biograph All 84 in the study were screened at Biograph, and every author works for Biograph.
“AI analysis of CT scans finds 42.9% of patients have coronary inflammation”
Biograph press release, 22 October 2026, on its medRxiv preprint using Caristo Diagnostics' CaRi-Heart Recorded 23 October 2026. Our ruling means: literally true, materially misleading.
Read the story →
Receipts pack
The evidence file for this verdict 11 receipts: 3 support the claim, 3 contradict it, 5 add context. 3 figures on the record, 2 traced to a quoted receipt.
The receipts Each source, the line we quote from it, its date and which way it cuts. Free to read and to cite.
1 Supports the claim medrxiv.org ↗ 22 Oct 2026
Elevated FAI-Score (≥75th percentile) was present in 42.9% of participants (36/84; 95% CI 32.8% - 53.5%) Look up an archived copy ↗
2 Context medrxiv.org ↗ 22 Oct 2026
84 consecutive asymptomatic adults (mean age 53.7 ± 8.6 years; 63.1% men) with no prior coronary artery disease underwent screening CCTA Look up an archived copy ↗
3 Contradicts the claim medrxiv.org ↗ 22 Oct 2026
all authors (DS, JF, MN, MD) are employees of Biograph and may hold stock or stock options in the company Look up an archived copy ↗
4 Contradicts the claim medrxiv.org ↗ 22 Oct 2026
received financial support from Biograph for the submitted work as employees of Biograph, which sponsored the study Look up an archived copy ↗
5 Context medrxiv.org ↗ 22 Oct 2026
quantifies vascular inflammation and predicts cardiac mortality in symptomatic cohorts Look up an archived copy ↗
6 Context medrxiv.org ↗ 22 Oct 2026
its prevalence, anatomical distribution, and clinical correlates in asymptomatic primary prevention populations remain uncharacterized Look up an archived copy ↗
7 Contradicts the claim medrxiv.org ↗ 22 Oct 2026
Systemic hs-CRP (median 0.8 mg/L) exhibited an inverse correlation with maximum vessel FAI-Score (Spearman ρ=−0.27, p=0.014) Look up an archived copy ↗
8 Context biograph.com ↗ 22 Oct 2026
The study, available to clinically eligible Biograph Black tier members Look up an archived copy ↗
9 Supports the claim biograph.com ↗ 22 Oct 2026
showed no correlation with the presence of coronary inflammation and failed to identify which patients had inflamed arteries Look up an archived copy ↗
10 Supports the claim biograph.com ↗ 22 Oct 2026
The study found that coronary inflammation is common (42.9%) in asymptomatic, low-risk adults Look up an archived copy ↗
11 Context hcplive.com ↗ 30 July 2026
Caristo's De Novo submission drew on validation data from large independent populations published in The Lancet Look up an archived copy ↗
Members' extras
What each receipt proves, and what would change our mind. What each receipt above proves, in our words The figures table, each number traced to the receipt that states it The trick behind the claim, explained, with the guide to spotting it What would change our verdict Our call on the record, with its due date The verdict, the opening and every receipt above stay free. Membership adds our analysis to the evidence file for every checked story.
First membership: 30 days free, then A$89 a year. One introductory trial per customer. Card required; renews annually until cancelled. Cancel before the trial ends to avoid the first charge.
Retry access check Members' extras need JavaScript. The receipts above work without it.